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Introduction
Dyslipidemia and high blood pressure in diabetic patients 
increase the risk of microvascular and macrovascular 
complications (1). Also disturbances of lipid metabolism 
associated to insulin resistance may be the primary event in 
the development of type 2 diabetes (1,2). The prevalence of 
hypertension is higher in diabetic patients than in nondiabetic 
individuals (3). Hypertension considerably increases the risk 
of nephropathy (3,4). Hypertension and dyslipidemia are often 
associated with insulin resistance and aggravation of diabetic 
kidney disease (3,4). Recently the close association of blood 
cholesterol and L-DL-C, with essential hypertension have 
shown (3,4), however limited studies have been conducted on 
the association of blood pressure with the dyslipidemia of type 
II diabetes patients.
Objectives
The aim of this prospective, observational study was to 
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Introduction: Dyslipidemia and high blood pressure in diabetic patients increase the risk of microvascular 
and macrovascular complications.
Objectives: This study was conducted to investigate the association between serum lipids and level of 
blood pressure in type 2 diabetic patients (T2D).
Patients and Methods: A prospective analytical study was carried out in 60 patients with T2D of both 
genders. None of the patients had a history of hypertension, and none was treated with antihypertensive 
drugs. Resting systolic blood pressures and fifth phase diastolic blood pressures were measured three 
times while the subjects were seated, and the results were averaged second and third measurements. Sixty 
patients with T2D were enrolled to the study. None of the patients who had a history of gout, was treated 
with allopurinol or treated with antihypertensive drugs previously.
Results: Of  60 participants, mean of serum creatinine was 0.98±0.22  mg/dL. Mean of systolic and 
diastolic blood pressure was 133±13 mmHg and 84±7.4 mmHg respectively. In this study, a significant 
positive correlation of serum cholesterol with systolic (r=0.598, p=0.001) and diastolic blood pressure 
(r=0.584, p=0.001) was seen. Also the associations of serum LDL-C with systolic and diastolic blood 
pressure were as follow (r = 0.335, p<0.001) and (0.491, p<0.001) respectively. Associations of HDL-C with 
systolic and diastolic blood pressure were not significance as follow -0.05 and 0.04 respectively.
Conclusion: The results of this study suggest that serum cholesterol has a strong association with levels 
of   systolic and diastolic blood pressure in T2D patients. More attention to serum lipids and treatment of 
dyslipidemia could halt the progress of diabetic kidney disease.
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Implication for health policy/practice/research/medical education:
A study was conducted, to investigate the association between serum lipids level and level of blood pressure in type 2 diabetes. Sixty patients 
with T2D was enrolled to the study. The results suggest that serum chlesterol and LDL-C have a significant association with levels of   systolic 
and diastolic blood pressure in type 2 diabetes patients. More attention to the serum lipid levels and treatment of dyslipidemia could halt the 
progress of diabetic kidney disease.
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determine whether baseline serum lipid levels are associated 
with level of blood pressure in T2D. 
Patients and Methods
Patients
A prospective analytical study was carried out in 60 patients 
with T2D of both genders. None of the patients had a history 
of hypertension and none was treated with antihypertensive 
drugs. Resting systolic blood pressures and fifth phase diastolic 
blood pressures were measured three times while the subjects 
were seated, and the results were averaged second and third 
measurements (5). Hypertension was defined as a blood 
pressure ≥140/90  mmHg or participant receiving current 
antihypertensive treatment (3,5). 
Laboratory methods
Venous blood samples were obtained in the fasting state for 
determinations of serum creatinine, uric acid and hemoglobin 
A1c (HbA1c) (reference range 4–6%). 24 hours urine proteinuria 
was measured too.
Ethical issues
(1) The research followed the tenets of the Declaration of 
Helsinki; (2) informed consent was obtained; (3) the research 
was approved by ethical committee of Shahrekord University of 
Medical Sciences.
Statistical analysis
Results were expressed as mean (SD) and were considered as 
statistically significant when p<0.05. Independent-student’s 
t-test was used for comparison of variables between male and 
female subjects. Spearman’s rho coefficient correlation for 
evaluating relations among variables. For association of serum 
lipids with levels of blood pressure the partial correlation 
test with adjustment for age, duration of diabetes and serum 
creatinine was used.
Results
Of 60 participants, 56.7% were female. Mean of age was 57 
(±8.3) years. Mean of diabetes duration was 9.2 (±4.9) years. 
Mean of serum creatinine was 0.98 (±0.22) mg/dL. Mean of 
systolic and diastolic blood pressure was 133 (±13) mmHg 
and 84± (7.4) mmHg respectively. Table 1 shows the imortant 
data of the patients. In this study, there was no significant 
difference of serum HbA1c and creatinine, between males and 
females (p>0.05). Similarly, there was no significant difference 
of proteinuria and levels of systolic or diastolic pressure 
between males and females (p>0.05). In this study, a significant 
positive correlation of serum cholesterol with systolic (r=0.598, 
p=0.001) and diastolic blood pressure (r=0.584, p=0.001) was 
seen. Also the association of serum LDL-C with systolic and 
diastolic blood pressure was (r= 0.335, p<0.001) and (0.491, 
p<0.001) respectively. Associations of HDL-C with systolic and 
diastolic blood pressure were not significance (-0.05 and 0.04 
respectively), however, there were negative. Statistical analysis 
regarding the associations of serum cholesterol and LDL-C 
with systolic and diastolic blood pressure per sex are shown in 
Table 2 and Figure 1. 
Discussion
In the present study, we found significant positive correlation 
of serum cholesterol and LDL-C with levels of systolic and 
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Table 1. Mean (SD) of systolic (BPSYS), diastolic (BPDIAS) blood pressure, serum cholesterol, LDL-C , HDL-C and TG in male and female subjects
Variable Male Female P Value
BPSYS 133.26 (13.7) 133.23 (13.2) 0.99
BPDIAS 84.61 (7.8) 83.67 (7.2) 0.632
CHOLESTROL 196.9 (70) 191.6 (58) 0.747
LDL-C 122.9 (94) 99 (30) 0.179
HDL-C 41.7 (7) 42.5 (8) 0.711
TG 279 (124) 220 (88) 0.032*
*P Value <0.05 was significance
Table 2. Correlation and partial correlation between systolic blood pressure (BPSYS), diastolic blood pressure (BPDIAS) and serum cholesterol, 
LDL-C, HDL-C and TG in male and females and comparison them
Variable Cholesterol LDL-C HDL-C TG-C Partial correlation
Male
BPSYS 0.594* 0.472* 0.149 0.249 0.502*
BPDIAS 0.579* 0.67* 0.2 0.37 0.272
Female
BPSYS 0.6* 0.16 -0.19 0.15 0.61*
BPDIAS 0.58* 0.22 -0.06 0.02 0.6*
total
BPSYS 0.598* 0.335* -0.05 0.05 0.565*
BPDIAS 0.584* 0.491* 0.04 0.197 0.473*
*P<0.05 and significance
Lipids and blood pressure in diabetics
45Journal of Renal Injury Prevention, Volume 3, Number 2, June 2014http://journalrip.com                
BPSYS
BPDias
Cholstrol
LDL
HDL 
TG
100 150 200 
70 80 
90 100 
70 80 90 100 
100 200 
300 400 
1 0 200 300 400 
0 200 
400 
200 400 
30 40 
50 60 
30 40 50 60 
0 200 
400 600 
BPSYS 
BPDias
Cholstrol
LDL
HDL 
TG
100 120 140 160 
70 80 
90 100 
70 80 90 100 
100 200 
300 
1 0 200 300 
50 100 
150 200 
50 100 150 200 
30 40 
50 60 
30 40 50 60 
0 200 
400 
BPSYS
BPDias
Cholstrol
LDL
HDL 
TG
100 150 200 
70 80 
90 100 
70 80 90 100 
100 200 
300 400 
1 0 200 300 400 
0 200 
400 
200 400 
20 40 
60 
20 40 60 
0 200 
400 600 
Male Female 
Total
Figure 1. Correlation between systolic blood pressure (BPSYS), diastolic blood pressure (BPDIAS) and cholesterol, LDL-C, HDL-C and TG in 
male and female patients.
diastolic blood pressure. In fact in addition to being associated 
of hypertension with increasing the risk of cardiovascular 
disease, dyslipidemia is also associated with an increased risk 
of kidney damage in patients with type 2 diabetes (7). Chronic 
kidney disease can increase the risk of cardiovascular disease 
too (4-6,8). Indeed, few attempts have been paid to analyze 
the relation between levels of blood pressure and dyslipidemia 
in individuals with T2DM. A relevant understanding of the 
interrelation between level of blood pressure and serum lipid 
levels may be through the understanding of how hypertension 
is related to the development of diabetic kidney disease and, 
thereby, aggravates by dyslipidemia (8,9). In a study on 1859 
patients were diagnosed as hypertension, Qiao et al. found 
blood cholesterol and  L-DL-C are associated closely with 
level of blood pressure (10). A recent cross-sectional survey on 
32004 patients showed that co-existence of high blood pressure 
and abnormal glucose metabolism is common in Chinese 
population (11). 
Conclusion
Hypertension and dyslipidemia both are aggravating factors 
of diabetic nephropathy, thus more attention to dyslipidemia 
and appropriate treatment of hypertension could attenuate 
progression of diabetic kidney disease.
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